1. Home
  2. SLXN

as 12-20-2024 4:00pm EST

$
0
1
2
3
4
5
6
7
8
9
.
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
+
$
0
1
2
3
4
5
6
7
8
9
.
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
+
0
1
2
3
4
5
6
7
8
9
.
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
%

Stocks

NYSE

Silexion Therapeutics Corp is a developmental-stage company dedicated to the development of treatments for pancreatic cancer. The company is focused on enhancing its first-generation product (LODERTM ) to develop a newly formulated product to improve the clinical efficacy against pancreatic cancer.

;00SMA (50)$1.12EMA (200)$6.81O: $2.12 H: $2.57 L: $2.12 C: $2.44 +0.32 (+15.09%)Elder Ray −0.32, −0.77
Founded: 2008 Country:
Israel
Israel
Employees: N/A City: RAMAT GAN
Market Cap: 5.2M IPO Year: N/A
Target Price: $1.00 AVG Volume (30 days): 1.3M
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -81.80 EPS Growth: N/A
52 Week Low/High: $0.21 - $13.56 Next Earning Date: 11-14-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use